Hawkins earnings release, May 13, 2026

Hawkins Inc (HWKN) · Form 8-K, Item 2.02 · Filed · SEC filing

Hawkins, Inc. Reports

Fourth Quarter and Fiscal Year 2026 Results

ROSEVILLE, Minn., May 13, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 29, 2026.

Fourth Quarter Fiscal Year 2026 Highlights:

• Record fourth quarter sales of $265.9 million, an 8% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 16% over the same quarter in the prior year. All segments grew revenue in the fourth quarter 2026.

• Record fourth quarter gross profit of $54.2 million, a 4% increase over the same quarter of the prior year.

• Fourth quarter diluted earnings per share (EPS) of $0.74, a decrease of $0.04, or 5%, due primarily to an approximately $4.4 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including the largest, WaterSurplus, which closed in the first quarter of fiscal 2026. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have been 9% higher than the comparable prior year.

• Fourth quarter operating cash flow of $37.7 million, an increase of $6.9 million, or 22% over the same quarter in the prior year.

Full-Year Fiscal Year 2026 Highlights:

• Sales of approximately $1.1 billion, an increase of $109.3 million, or 11% from fiscal 2025.

• Gross profit of $245.1 million, an increase of $19.5 million, or 9% from fiscal 2025.

• Operating cash flow of $144.3 million, an increase of $33.2 million, or 30% from fiscal 2025.

• Diluted earnings per share (EPS) of $3.91, a decrease of $0.12, or 3%, from fiscal 2025, due primarily to an approximately $16.5 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including WaterSurplus. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have increased by $0.32, or 9%, over the prior fiscal year.

• Net income was $81.5 million, while Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA), a non-GAAP measure, was $179.0 million, an increase of 6% over the prior fiscal year.

• Continued our acquisitions strategy and closed on six transactions during the fiscal year, mainly focused on accelerating growth in the Water Treatment segment.

• Paid cash dividends of $0.75 per share for the year, an increase of 7% over the prior year, marking our 41st consecutive year of paying a dividend.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Fiscal 2026 was another milestone year for our company, as we crossed $1 billion in revenue, for the first time in our history. My thanks to every person connected to our great company for helping us accomplish this goal. This achievement resulted in a number of records for the year; including sales, gross margin, operating income, and adjusted EBITDA.

Our focus has long been to deliver sustained growth over time, and we have continued to execute on that with pro forma EPS growth for the eighth consecutive year."

Mr. Hawkins continued, "Our disciplined M&A strategy remained a core competency for us and has again contributed to growth of Water Treatment, our largest reporting segment, which now represents 50% of our total company revenue and 56% of the total company operating income. We have completed 17 acquisitions over the last five years, most of which have helped to drive accelerated growth in our Water Treatment segment and we expect future acquisitions to continue to be focused on Water Treatment. With our latest deals, we now have a full product portfolio for our Water Treatment customers, including chemicals, media and filtration products, and equipment."

Mr. Hawkins continued, “Our Water Treatment segment achieved sales growth of 22% for the year, through sales from our acquired companies as well as organic growth. Sales in our Food and Health Sciences segment were relatively flat, mainly due to softness in the food and nutrition end markets, and our Industrial Solutions segment was up 6% for the year."

Mr. Hawkins concluded, “Looking ahead to fiscal 2027, we are well positioned to grow revenue and operating income in each of our business segments and expect EPS to grow as well. We expect our balance sheet to remain strong, and with the diversity of our businesses and the overall strength of our company, we believe we will continue to generate strong operating cash flow. This will allow us to fund future growth investments and continue to pay down our debt during fiscal year 2027 as we expect to achieve a leverage ratio of approximately 1x adjusted EBITDA by the end of fiscal year 2027.”

Fourth Quarter and Fiscal Year Financial Highlights:

NET INCOME

For the fourth quarter of fiscal 2026, the company reported net income of $15.5 million, or $0.74 per diluted share, compared to net income for the fourth quarter of fiscal 2025 of $16.3 million, or $0.78 per diluted share.

For the full year, the Company reported record net income of $81.5 million, or $3.91 per diluted share, compared to net income for fiscal 2025 of $84.3 million, or $4.03 per diluted share.

REVENUE... (truncated)0.3 million, or less than 1%, to $88.6 million for the fourth quarter, as compared to $88.3 million for the same period a year ago. Sales increased slightly with increased volumes of our Agricultural products, mostly offset by lower selling prices. Industrial Solutions segment sales increased $3.0 million, or 6%, to $55.0 million for the fourth quarter, as compared to $52.0 million for the same period a year ago. Sales increased primarily as a result of increased sales of certain of our manufactured, blended and repackaged products.

For fiscal 2026, sales were $1,083.7 million, an increase of $109.3 million, or 11%, from sales of $974.4 million a year ago. Water Treatment segment sales were $543.3 million for the year, an increase of 22% over last year’s sales of $446.5 million; of the $96.8 million increase, $83.3 million was from our acquired businesses in fiscal 2026. Sales for our Food and Health Sciences segment were $320.7 million in fiscal 2026, a decrease of 1%, from fiscal 2025 sales of $322.6 million. Industrial Solutions segment sales were $219.7 million, an increase of 7% from fiscal 2025 sales of $205.4 million.

GROSS PROFIT

Gross profit for fiscal 2026 increased $19.5 million, or 9%, to $245.1 million, or 23% of sales, from $225.5 million, or 23% of sales, for fiscal 2025. During fiscal 2026, the LIFO reserve increased, and gross profits decreased, by $1.5 million, of which $0.8 million occurred in the fourth quarter, primarily due to rising material costs. During fiscal 2025, the LIFO reserve decreased, and gross profit increased, by $1.6 million, most of which occurred in the fourth quarter. Gross profit increased due to increased sales, partially offset by the unfavorable year-over-year impact of the increased LIFO reserve.

Gross profit for the Water Treatment segment increased $23.2 million, or 19%, to $145.0 million, or 27% of sales, for fiscal 2026, from $121.8 million, or 27% of sales, for fiscal 2025. Gross profit increased as a result of the increased sales.

Gross profit for our Food and Health Sciences segment decreased $4.6 million, or 6%, to $67.3 million, or 21% of sales, for fiscal 2026, from $71.9 million, or 22% of sales, for fiscal 2025. Gross profit decreased as a result of lower selling prices as a result of competitive pricing pressures.

Gross profit for the Industrial Solutions segment increased $1.0 million, or 3%, to $32.8 million, or 15% of sales, for fiscal 2026, from $31.8 million, or 15% of sales, for fiscal 2025. Gross profit increased as a result of the increase in sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

SG&A expenses increased $17.4 million, or 16%, to $123.8 million, or 11% of sales, for fiscal 2026, from $106.4 million, or 11% of sales, for fiscal 2025. Expenses increased largely due to $19.3 million in added costs from the acquired business in our Water Treatment segment, including amortization of intangibles of $8.9 million, fair value accretion on the WaterSurplus earnout liability of $1.9 million, as well as increased variable costs. This was partially offset by a reduction of $8.1 million to the Water Solutions earnout.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended March 29, 2026, was $37.2 million, an increase of $0.2 million, or 1%, from adjusted EBITDA of $37.0 million for the same period in the prior year. Full-year adjusted EBITDA was $179.0 million, an increase of $10.2 million, or 6%, from adjusted EBITDA of $168.9 million for fiscal 2025. The increase was due to the impact of improved gross profits discussed above.

INCOME TAXES

Our effective tax rate was approximately 25% for fiscal 2026 and 26% for fiscal 2025. The current year decrease in the effective tax rate was primarily driven by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. For fiscal 2027, we expect the income tax rate to be between 25% to 27%.

Financial statements

Income Statement

Adjusted EBITDA (in thousands)

Three Months Ended – March 29, 2026Three Months Ended – March 30, 2025Fiscal Year Ended – March 29, 2026Fiscal Year Ended – March 30, 2025
Net income (GAAP)15,46316,32781,54884,345
Interest expense, net2,9721,52613,5075,432
Income tax expense4,4616,09527,79230,038
Amortization of intangibles5,4943,55321,29212,764
Depreciation expense8,0857,02731,25027,184
Non-cash compensation expense2,1351,4768,5736,498
Non-recurring acquisition expense186491,2391,229
Non-cash earnout related expense-1,410342-6,1771,375
Adjusted EBITDA37,21836,995179,024168,865

Income Statement

Three Months Ended — (In thousands, except share and per-share data)

Three Months Ended – March 29, 2026 – (unaudited)Three Months Ended – March 30, 2025 – (unaudited)Fiscal Year Ended – March 29, 2026Fiscal Year Ended – March 30, 2025
Sales265,910245,3181,083,696974,431
Cost of sales-211,673-193,081-838,641-748,893
Gross profit54,23752,237245,055225,538
Selling, general and administrative expenses-30,773-27,662-123,762-106,364
Operating income23,46424,575121,293119,174
Interest expense, net-2,972-1,526-13,507-5,432
Other income (expense)-568-6271,554641
Income before income taxes19,92422,422109,340114,383
Income tax expense-4,461-6,095-27,792-30,038
Net income15,46316,32781,54884,345
Weighted average number of shares outstanding-basic20,751,74720,728,52820,736,81520,803,872
Weighted average number of shares outstanding-diluted20,870,81020,848,11820,861,86020,936,502
Basic earnings per share0.750.793.934.05
Diluted earnings per share0.740.783.914.03

Income Statement

Water Treatment — (In thousands) (in thousands)

Fiscal Year Ended March 29, 2026: – Water TreatmentFiscal Year Ended March 29, 2026: – Food and Health SciencesFiscal Year Ended March 29, 2026: – Industrial SolutionsFiscal Year Ended March 29, 2026: – Total
Sales543,303320,700219,6931,083,696
Cost of sales - materials-327,821-233,960-174,415-736,196
Cost of sales - operational overhead-70,529-19,408-12,508-102,445
Gross profit144,95367,33232,770245,055
Selling, general, and administrative expenses-76,865-32,981-13,916-123,762
Operating income68,08834,35118,854121,293
Fiscal Year Ended March 30, 2025:Sales446,489322,560205,382974,431
Fiscal Year Ended March 30, 2025:Cost of sales - materials-259,722-231,621-160,199-651,542
Fiscal Year Ended March 30, 2025:Cost of sales - operational overhead-64,934-19,021-13,396-97,351
Fiscal Year Ended March 30, 2025:Gross profit121,83371,91831,787225,538
Fiscal Year Ended March 30, 2025:Selling, general, and administrative expenses-62,287-30,720-13,357-106,364
Fiscal Year Ended March 30, 2025:Operating income59,54641,19818,430119,174

Balance Sheet (in thousands)

Return on Equity($ in thousands)Fiscal Year Ended March 29, 2026
Return on EquityNet income (GAAP)81,548
Return on EquityShareholders' equity at beginning of period460,292
Return on EquityShareholders' equity at end of period534,009
Return on EquityAverage shareholders' equity497,151
Return on EquityReturn on equity16.4

Balance Sheet

March 29, 2026 — (In thousands, except share and per-share data)

March 29, 2026March 30, 2025
CURRENT ASSETS:Cash and cash equivalents3,9145,103
CURRENT ASSETS:Trade accounts receivables, net139,796131,795
CURRENT ASSETS:Inventories78,19983,512
CURRENT ASSETS:Income taxes receivable8912,864
CURRENT ASSETS:Prepaid expenses and other current assets8,6657,417
CURRENT ASSETS:Total current assets231,465230,691
PROPERTY, PLANT, AND EQUIPMENT:Land21,22318,679
PROPERTY, PLANT, AND EQUIPMENT:Buildings and improvements193,210163,913
PROPERTY, PLANT, AND EQUIPMENT:Machinery and equipment175,495150,981
PROPERTY, PLANT, AND EQUIPMENT:Transportation equipment89,22078,064
PROPERTY, PLANT, AND EQUIPMENT:Office furniture and equipment10,5149,316
PROPERTY, PLANT, AND EQUIPMENT:489,662420,953
PROPERTY, PLANT, AND EQUIPMENT:Less accumulated depreciation223,406195,667
PROPERTY, PLANT, AND EQUIPMENT:Net property, plant, and equipment266,256225,286
OTHER ASSETS:Right-of-use assets16,84013,449
OTHER ASSETS:Goodwill223,042135,409
OTHER ASSETS:Intangible assets, net232,887150,121
OTHER ASSETS:Deferred compensation plan assets12,81211,185
OTHER ASSETS:Other assets2,9883,907
OTHER ASSETS:Total other assets488,569314,071
OTHER ASSETS:Total assets986,290770,048
CURRENT LIABILITIES:Accounts payable — trade59,83561,195
CURRENT LIABILITIES:Accrued payroll and employee benefits20,09219,659
CURRENT LIABILITIES:Short-term lease liabilities3,0002,900
CURRENT LIABILITIES:Contract liability1,580
CURRENT LIABILITIES:Accrued real estate taxes1,2241,030
CURRENT LIABILITIES:Current portion of deferred compensation liability1,334538
CURRENT LIABILITIES:Container deposits1,3831,914
CURRENT LIABILITIES:Current portion of earnout liability4,529
CURRENT LIABILITIES:Environmental remediation7,7007,700
CURRENT LIABILITIES:Other current liabilities4,1672,286
CURRENT LIABILITIES:Total current liabilities104,84497,222

Balance Sheet

March 29, 2026 — (In thousands, except share and per-share data)

March 29, 2026March 30, 2025
LONG-TERM LIABILITIES:Long-term debt244,000149,000

Cash Flow

Fiscal Year Ended — (In thousands) (in thousands)

Fiscal Year Ended – March 29, 2026Fiscal Year Ended – March 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:Net income81,54884,345
Reconciliation to cash flows:Depreciation and amortization52,54239,948
Reconciliation to cash flows:Change in fair value of earnout liability-6,1771,369
Reconciliation to cash flows:Operating leases3,9823,475
Reconciliation to cash flows:Gain on deferred compensation assets-1,554-641
Reconciliation to cash flows:Deferred income taxes3,053461
Reconciliation to cash flows:Stock compensation expense8,5736,498
Reconciliation to cash flows:Gain from asset disposals-202-61
Reconciliation to cash flows:Other, net17987
Changes in operating accounts (using) providing cash, net of acquisitions:Trade receivables-2,467-11,230
Changes in operating accounts (using) providing cash, net of acquisitions:Inventories10,053-6,572
Changes in operating accounts (using) providing cash, net of acquisitions:Accounts payable-5,8412,445
Changes in operating accounts (using) providing cash, net of acquisitions:Accrued liabilities2,195476
Changes in operating accounts (using) providing cash, net of acquisitions:Lease liabilities-3,775-3,468
Changes in operating accounts (using) providing cash, net of acquisitions:Income taxes2,071-4,807
Changes in operating accounts (using) providing cash, net of acquisitions:Other, net147-1,229
Changes in operating accounts (using) providing cash, net of acquisitions:Net cash provided by operating activities144,327111,096
CASH FLOWS FROM INVESTING ACTIVITIES:Additions to property, plant, and equipment-58,239-41,096
CASH FLOWS FROM INVESTING ACTIVITIES:Acquisitions-167,108-87,400
CASH FLOWS FROM INVESTING ACTIVITIES:Proceeds from asset disposals1,248544
CASH FLOWS FROM INVESTING ACTIVITIES:Net cash used in investing activities-224,099-127,952
CASH FLOWS FROM FINANCING ACTIVITIES:Cash dividends paid-15,665-14,635
CASH FLOWS FROM FINANCING ACTIVITIES:ESPP shares issued3,0402,658
CASH FLOWS FROM FINANCING ACTIVITIES:Shares surrendered for payroll taxes-3,028-2,541
CASH FLOWS FROM FINANCING ACTIVITIES:Shares repurchased-20,676
CASH FLOWS FROM FINANCING ACTIVITIES:Payments for debt issuance costs-764
CASH FLOWS FROM FINANCING ACTIVITIES:Payments on senior secured revolving loan-75,000-60,000
CASH FLOWS FROM FINANCING ACTIVITIES:Borrowings on senior secured revolving loan170,000110,000
CASH FLOWS FROM FINANCING ACTIVITIES:Net cash provided by (used in) financing activities78,58314,806
CASH FLOWS FROM FINANCING ACTIVITIES:NET DECREASE IN CASH AND CASH EQUIVALENTS-1,189-2,050
CASH FLOWS FROM FINANCING ACTIVITIES:CASH AND CASH EQUIVALENTS - beginning of year5,1037,153
CASH FLOWS FROM FINANCING ACTIVITIES:CASH AND CASH EQUIVALENTS - end of year3,9145,103
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION-Cash paid during the year for income taxes, net of refunds22,68534,386
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION-Cash paid for interest13,6505,785
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION-Noncash investing activities - Capital expenditures in accounts payable2,5361,841

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Hawkins earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.